Insider buying
~$36K10K sh @ $3.62
Traded Nov 14, 2024 · filed 5 days later
A Tango Therapeutics director paid $36K out of pocket for Tango Therapeutics shares. It was the first purchase in over a year. Shares held went up 89% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
2 tracked managers disclosed the same change for Q3 2024. From a 13F filed Nov 14, 2024 covering holdings at Sep 30, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q2 2024 13F
5,276,699
5,000,000
−5.2%
Share count drives classification; reported value also moves with price
0.91%
Within the filing's reported positions, not the manager's total assets
2
For Q3 2024
Insider buying
Traded Nov 14, 2024 · filed 5 days later
A Tango Therapeutics director paid $36K out of pocket for Tango Therapeutics shares. It was the first purchase in over a year. Shares held went up 89% with this purchase.
Insider buying
Traded Nov 18, 2024 · filed 1 day later
A Tango Therapeutics director paid $38K out of pocket for Tango Therapeutics shares. Shares held went up 47% with this purchase.
Insider selling
Traded Nov 6, 2024 · filed 3 days laterNot reported under a pre-arranged trading plan
A major shareholder of Tango Therapeutics sold $4.9M of Tango Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.